530
Views
0
CrossRef citations to date
0
Altmetric
Articles

Cost of arthropathic diseases therapy with biologicals disease modifying drugs (bDMARs): a 5-year cost analysis at national level

, , , , , & show all
Pages 828-837 | Received 20 Jun 2022, Accepted 20 Sep 2022, Published online: 19 Oct 2022

Figures & data

Table 1. Reimbursed cost per diagnosis during 2016–2020 (BGN).

Table 2. Reimbursed medicines, cost, and utilization indicators.

Figure 1. Relative share of the INN expenditures.

Figure 1. Relative share of the INN expenditures.

Figure 2. Total cost (TC) per year for all observed INNs.

Figure 2. Total cost (TC) per year for all observed INNs.

Table 3. Cost data correlation analysis.

Table 4. Correlation analysis between prices, utilization, and reimbursed cost of observed INNs.

Data availability statement

The data used for the analysis are available from the corresponding author upon reasonable request.